Introduction
Studies on boron neutron capture therapy BNCT have recently begun garnering attention. It is a cancer treatment method that exploits the nuclear reaction between boron and thermal neutrons, and is based on nuclear capture and fission reactions. Naturally occurring elemental boron has the following two stable isotopes: boron-10 10 B and boron-11 11 B . When 10 B is irradiated with low-energy thermal neutrons, it yields high linear energy transfer LET , α particles 4 He , and recoiling lithium-7 7 Li nuclei. The destructive effects of these high-energy particles are limited to boron-containing cells since the path length of high LET particles in tissue is limited 5-9 µm . Therefore, BNCT can theoretically kill tumor cells without affecting adjacent healthy cells if 10 B atoms can be selectively delivered and accumulated in the interstitial space of tumor of boron compound-loaded PLGA nanoparticles exceeded 20-30 µg/g of tissue, and the average tumor/blood boron concentration ratio exceeded 5 by 4-12 h post-tail vein injection. In addition, as a result of utilizing PLGA in nanoparticulation, the boron concentration in the tumor was 1.7-3.2 times higher than that of boron compound-albumin conjugate 5 . Although PLGA nanoparticles are thought to be useful for BNCT boron delivery, the influence of surface modification has not yet been investigated. In this study, we prepared boron compound-loaded PLGA nanoparticles coated with chitosan to improve the cellular uptake of nanoparticles. Since chitosan, which is a natural biopolymer cation, adsorbs anions 11 , it is assumed that chitosan-coated PLGA nanoparticles effectively adhere to negatively charged cell surfaces. Studies on the cellular uptake mechanism of chitosan nanoparticles have been re-
which is a hydrophobic boron compound, was used as a boron carrier because dicarba-closo-dodecaborane has 10 boron atoms in its structure; furthermore, this boron compound is stable in the presence of many chemical reagents, and has significant thermal stability 13 17 . Chitosan hydroxypropyltrimonium chloride CS was used as chitosan, which can easily modify the surface of PLGA nanoparticles 18 . The physicochemical properties of the nanoparticles, including the surface charge number density, were measured, and the cellular uptake of nanoparticles by B16 melanoma cells was qualitatively and quantitatively assessed. The number of boron atoms per cell was also measured.
Experimental Procedures

Materials
PLGA monomer composition of DL-lactic acid/glycolic a c i d 7 5 / 2 5 w i t h a m o l e c u l a r w e i g h t o f 1 0 , 0 0 0 PLGA7510 , o-Carborane C 2 H 12 B 10 , purity ≥ 97 , polyvinyl alcohol PVA, degree of polymerization: 500 , boron standard solution boron concentration: 1000 mg/L , and Dulbecco s modified Eagle medium DMEM, low glucose, with L-glutamine and phenol red were purchased from Wako Pure Chemical Industries, Ltd. Osaka, Japan . Fetal bovine serum FBS was purchased from Thermo Fisher Scientific, Inc. Waltham, MA . 4 ,6-Diamidino-2-phenylindole dihydrochloride DAPI was purchased from Nacalai Tesque Inc. Kyoto, Japan . Coumarin-6 C 20 H 18 N 2 O 2 S, purity 98 was purchased from Sigma-Aldrich St. Louis, MO . CS Mw: 100,000-200,000 was kindly donated by Katakura & Co-op Agri Corp. Tokyo, Japan . All other chemicals were of the highest grade commercially available.
Preparation of o-Carborane-loaded PLGA nanopar-
ticles coated with CS o-Carborane-loaded PLGA nanoparticles bare nanoparticles were prepared via an emulsion solvent evaporation method 5 . 90 mg of PLGA7510 and 10 mg of o-Carborane were briefly dissolved in a mixture of 1.0 mL of dichloromethane and 1.0 mL of acetone. The solution was added to 10 mL of 2.0 w/v PVA aqueous solution and emulsified by operating a probe sonicator Digital Sonifier S-250D, Branson Ultrasonics Corp., Danbury, CT at 200 W of energy output. To prepare nanoparticles with a diameter of approximately 100 nm, sonication was carried out for 1.5 min. in an ice bath. The O/W emulsion was stirred overnight by using a magnetic stir plate at room temperature to evaporate the dichloromethane and acetone. The nanoparticles were then collected by performing ultracentrifugation at 40,000 rpm for 20 min. Himac 80WX, Hitachi Koki Co. Ltd., Tokyo, Japan . Following centrifugation, the precipitated nanoparticles were rinsed with purified water in an ultrasonic bath sonicator to remove residual PVA. Centrifugation and rinsing were repeated for a total of three cycles. o-Carborane-loaded PLGA nanoparticles coated with CS CS-coated nanoparticles were prepared from bare nanoparticles. Bare nanoparticles were redispersed in purified water, and the suspension was mixed with equivalent amounts of 0.05 w/v CS solution. Then, CS-coated nanoparticles were obtained 19, 20 .
The mean volume diameter and size distribution of the prepared bare and CS-coated nanoparticles were respectively measured by using a particle size analyzer ELSZ-2, Otsuka Electronics Co., Ltd., Osaka, Japan . Additionally, the electrophoretic mobility of the nanoparticles was measured in nine types of 37 physiological saline solutions that only differed by ionic strength I . The data were analyzed by using Ohshima s electrokinetic theory for soft particles 21 to calculate the particle surface charge number density 18, 22 24 . The o-Carborane content in the prepared particles was determined by performing inductively coupled plasma atomic emission spectroscopy ICP-AES , ICPE-9000 Shimadzu Corp., Kyoto, Japan at 249.773 nm.
To obtain the measurement, a solution prepared by dissolving 10 mg of nanoparticles in 30 mL of acetonitrile was used. A calibration curve was prepared by using boron standard solution. All ICP-AES measurements were carried out under the same conditions. Morphological observation of the nanoparticles was carried out by using a scanning electron microscope SEM, JSM-6060LA, JEOL Ltd., Akishima, Japan .
2.3
In vitro release study of bare and CS-coated nanoparticles To evaluate the influence of CS modification on drug release behavior, the release rate of o-Carborane from the nanoparticles was investigated via a dialysis membrane method 25 . Bare or CS-coated nanoparticles were redispersed in 5.0 mL of phosphate-buffered saline PBS, pH 7.4 to a boron concentration of 10 mg/L. The suspension was placed in a dialysis tubing cellulose membrane UC20-32-100, molecular weight cut off: 14,000, EIDIA Co., Ltd., Tokyo, Japan and added to 95 mL of PBS pH 7.4 . The sample suspensions were shaken at 50 rpm at 37 . After 0.5, 1.0, 2.0, 4.0, 8.0, and 12.0 h, the samples were extracted, and the amount of released o-Carborane was quantified by performing ICP-AES.
2.4
In vitro cellular uptake tests for bare and CS-coated nanoparticles To observe the cellular uptake of CS-coated nanoparticles, we prepared fluorescent nanoparticles containing coumarin-6 CS-coated fluorescent nanoparticles . Bare fluorescent nanoparticles were also prepared for comparison. Coumarin-6 was used as a trace marker of the PLGA nanoparticles 18 . Ninety milligrams of PLGA, 9.9 mg of oCarborane, and 100 µg of coumarin-6 were dissolved in a mixture of 1.0 mL of dichloromethane and 1.0 mL of acetone. Nanoparticle preparation was carried out in the same manner as described in Section 2. The cellular uptakes of bare and CS-coated fluorescent nanoparticles were quantitatively assessed by using fluorescence-activated cell sorting FACS, BD FACSCalibur, BD Bioscience, San Jose, CA . Two milliliters of the suspension of B16 melanoma cells was seeded in 6-well plates at 4.0 10 5 cells/well and cultured for 24 h at 37 in a 5 CO 2 atmosphere. The nanoparticles suspensions were added to a coumarin-6 concentration of 0.5 µg/L, and they were further cultured for 4 h at 37 in a 5 CO 2 atmosphere. After washing with PBS, the cells were disaggregated by using trypsin-EDTA and centrifuged at 300 g for 5 min. to remove the supernatant. Then, the collected cells were dispersed in a FACS buffer solution 29 . PBS was used as a control.
To confirm the number of boron atoms in the B16 melanoma cells, the cellular boron concentration was measured via ICP-AES. Two milliliters of the suspension of B16 melanoma cells was seeded in 6-well plates at 4.0 10 5 cells/ well and cultured for 24 h at 37 in a 5 CO 2 atmosphere.
The nanoparticles suspensions were added to a boron concentration of 40.0 µg/L, and they were further cultured for 2 h at 37 in a 5 CO 2 atmosphere. After washing with PBS, the cells were disaggregated by using trypsin-EDTA and centrifuged at 300 g for 5 min. to remove the supernatant. For measurement, the cells were treated with nitric acid.
3 Results and Discussion 3.1 Characterization of bare and CS-coated nanoparticles Bare nanoparticles and CS-coated nanoparticles with respective mean volume diameters of 111.4 30.1 and 113. 6 32.5 nm were prepared. Their particle size distributions are shown in Fig. 1 . In the previous study in which chitosan was modified for compatibility with PLGA nanoparticles prepared without using PVA, the mean volume diameter of nanoparticles increased as a result of modifying chitosan 18 .
In contrast, the surface of the nanoparticles used in this study were covered with PVA. The influence of the PVA on the mean volume diameter of the nanoparticles may be more significant than that of the chitosan modification. The o-Carborane contents of bare and CS-coated nanoparticles were 5.61 0.85 and 5.18 0.16 , respectively. Figure 2 presents the SEM images of the nanoparticles that show dispersed spherical particles. Their electrophoretic mobility was also measured, and the results are shown in Fig. 3 ; additionally, the particle surface charge number density was calculated. The results of the procedures shown as a solid line in Fig. 3 revealed particle surface charge number densities of -1.91 mM and 20.8 mM for the bare and CScoated nanoparticles, respectively. The value of the surface charge number density of nanoparticles changed from neg- ative to positive as a result of coating bare nanoparticles with CS. This finding indicates that the particle surface was fully covered with CS, and that the PLGA-derived negative charge was shielded 18, 30, 31 . According to these findings, we have confirmed that the CS-coated nanoparticles were successfully prepared.
o-Carborane release from bare and CS-coated nanoparticles
The cumulative release rate of o-Carborane from bare or CS-coated nanoparticles in 37 PBS is shown in Fig. 4 . As compared to bare nanoparticles, CS-coated nanoparticles released significantly less o-Carborane in 0.5-1.0 h. In this study, CS was modified after preparation of o-Carboraneloaded nanoparticles. Therefore, as CS covered the nanoparticle surface, it is considered that the release of oCarborane near the surface of the nanoparticle, which affects the initial burst, was suppressed. In addition, it is suggested that, when the glass transition temperature T g of the drug carrier is higher than the ambient temperature, the initial burst of the drug from the nanoparticles is suppressed 32, 33 . Since the T g of chitosans was reported to be very high 34, 35 , it is possible that the T g of the CS covering the nanoparticles influenced the drug release behavior.
3.3
In vitro cellular uptake of bare and CS-coated nanoparticles To assess whether the nanoparticles were actually internalized within B16 melanoma cells, CLSM observation was performed. As shown in Fig. 5 , the nanoparticles green . a B a r e n a n o p a r t i c l e s . b N a n o p a r t i c l e s c o a t e d w i t h c h i t o s a n hydroxypropyltrimonium chloride. spots exist around the cell nucleus blue stained line , and are localized in the cytoplasm. However, there is a clear difference between the bare and CS-coated fluorescent nanoparticles. Specifically, as compared to the bare fluorescent nanoparticles, the CS-coated fluorescent nanoparticles appear to be taken up by cells in larger amounts. Analyzing the FACS measurement results revealed that the mean fluorescence intensity of the CS-coated fluorescent nanoparticles was three times higher than that of the bare fluorescent nanoparticles Fig. 6a . This result is consistent with the CLSM observation results. It is suggested that the internalization of chitosan nanoparticles by cells predominantly occurs via adsorptive endocytosis initiated by nonspecific interactions between nanoparticles and cell membranes, and is mediated in part by clathrin-mediated processes 12 . We believe that coating the nanoparticles with CS successfully improved adhesion to negatively charged cell surfaces because the surface of the particles was positively charged as a result of CS modification. Figure 6b shows the number of boron atoms per B16 melanoma cell. In BNCT, it is necessary to deliver at least 1.0 10 9 10 B atoms to each targeted cell to ensure that the total dose to the tumor significantly exceeds the dose to the surrounding normal tissue. This amount of boron corresponds to ap- 36 . Bare and CScoated nanoparticles exceeded this quantity; however, the number of boron atoms per cell of CS-coated nanoparticles was 1.8 times higher than that of bare nanoparticles.
Conclusion
CS-coated nanoparticles were prepared to have a mean volume diameter of 110-nm. The results of investigation into the cellular uptake in B16 melanoma cells have shown that CS-coated nanoparticles are more favorable for cellular uptake than bare nanoparticles, and are the preferred formulations for BNCT. The effectiveness of the CS-coated nanoparticles developed in this study can be further improved by examining their particle size and the PLGA composition. The affinity of nanoparticles for cancer cells is expected to be improved by using folic acid or transferrin 37, 38 .
Additionally, it is necessary to conduct an in vitro tumor accumulation test in the future. Fig. 6 a Mean fluorescence intensity of control PBS , o-carborane-loaded PLGA nanoparticles bare nanoparticles , and o-carborane-loaded PLGA n a n o p a r t i c l e s c o a t e d w i t h c h i t o s a n hydroxypropyltrimonium chloride CS-coated nanoparticles mean S.D., n 3, ** p 0.01, Tukey s test . b Number of boron atoms per B16 m e l a n o m a c e l l w h e n b a r e o r C S -c o a t e d nanoparticles were added mean S.D., n 3, ** p 0.01, t-test .
